IL1A and Urinary incontinence: In relation to measures of incontinence, the concentration of IL-1α was found to significantly increase with pad weight (P = 0.007, Table 4), while IL-1 receptor antagonist concentration decreased as the average frequency of voids per day increased (P 0.039).